Global Attention Deficit Hyperactivity Disorder Market Research Report 2023

Report ID: 1900842 | Published Date: Jan 2025 | No. of Page: 81 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Attention Deficit Hyperactivity Disorder Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Stimulants Drugs
        1.2.3 Non-stimulants Drugs
    1.3 Market by Application
        1.3.1 Global Attention Deficit Hyperactivity Disorder Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Pediatric
        1.3.3 Adolescent
        1.3.4 Adults
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Attention Deficit Hyperactivity Disorder Market Perspective (2017-2028)
    2.2 Attention Deficit Hyperactivity Disorder Growth Trends by Region
        2.2.1 Attention Deficit Hyperactivity Disorder Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Attention Deficit Hyperactivity Disorder Historic Market Size by Region (2017-2022)
        2.2.3 Attention Deficit Hyperactivity Disorder Forecasted Market Size by Region (2023-2028)
    2.3 Attention Deficit Hyperactivity Disorder Market Dynamics
        2.3.1 Attention Deficit Hyperactivity Disorder Industry Trends
        2.3.2 Attention Deficit Hyperactivity Disorder Market Drivers
        2.3.3 Attention Deficit Hyperactivity Disorder Market Challenges
        2.3.4 Attention Deficit Hyperactivity Disorder Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Attention Deficit Hyperactivity Disorder Players by Revenue
        3.1.1 Global Top Attention Deficit Hyperactivity Disorder Players by Revenue (2017-2022)
        3.1.2 Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Players (2017-2022)
    3.2 Global Attention Deficit Hyperactivity Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Attention Deficit Hyperactivity Disorder Revenue
    3.4 Global Attention Deficit Hyperactivity Disorder Market Concentration Ratio
        3.4.1 Global Attention Deficit Hyperactivity Disorder Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Attention Deficit Hyperactivity Disorder Revenue in 2021
    3.5 Attention Deficit Hyperactivity Disorder Key Players Head office and Area Served
    3.6 Key Players Attention Deficit Hyperactivity Disorder Product Solution and Service
    3.7 Date of Enter into Attention Deficit Hyperactivity Disorder Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Attention Deficit Hyperactivity Disorder Breakdown Data by Type
    4.1 Global Attention Deficit Hyperactivity Disorder Historic Market Size by Type (2017-2022)
    4.2 Global Attention Deficit Hyperactivity Disorder Forecasted Market Size by Type (2023-2028)
5 Attention Deficit Hyperactivity Disorder Breakdown Data by Application
    5.1 Global Attention Deficit Hyperactivity Disorder Historic Market Size by Application (2017-2022)
    5.2 Global Attention Deficit Hyperactivity Disorder Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Attention Deficit Hyperactivity Disorder Market Size (2017-2028)
    6.2 North America Attention Deficit Hyperactivity Disorder Market Size by Country (2017-2022)
    6.3 North America Attention Deficit Hyperactivity Disorder Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Attention Deficit Hyperactivity Disorder Market Size (2017-2028)
    7.2 Europe Attention Deficit Hyperactivity Disorder Market Size by Country (2017-2022)
    7.3 Europe Attention Deficit Hyperactivity Disorder Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size (2017-2028)
    8.2 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Country (2017-2022)
    8.3 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Attention Deficit Hyperactivity Disorder Market Size (2017-2028)
    9.2 Latin America Attention Deficit Hyperactivity Disorder Market Size by Country (2017-2022)
    9.3 Latin America Attention Deficit Hyperactivity Disorder Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size (2017-2028)
    10.2 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Country (2017-2022)
    10.3 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Eli Lilly
        11.1.1 Eli Lilly Company Detail
        11.1.2 Eli Lilly Business Overview
        11.1.3 Eli Lilly Attention Deficit Hyperactivity Disorder Introduction
        11.1.4 Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022)
        11.1.5 Eli Lilly Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Detail
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Attention Deficit Hyperactivity Disorder Introduction
        11.2.4 Novartis Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022)
        11.2.5 Novartis Recent Development
    11.3 Takeda
        11.3.1 Takeda Company Detail
        11.3.2 Takeda Business Overview
        11.3.3 Takeda Attention Deficit Hyperactivity Disorder Introduction
        11.3.4 Takeda Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022)
        11.3.5 Takeda Recent Development
    11.4 Pfizer
        11.4.1 Pfizer Company Detail
        11.4.2 Pfizer Business Overview
        11.4.3 Pfizer Attention Deficit Hyperactivity Disorder Introduction
        11.4.4 Pfizer Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022)
        11.4.5 Pfizer Recent Development
    11.5 GlaxoSmithKline
        11.5.1 GlaxoSmithKline Company Detail
        11.5.2 GlaxoSmithKline Business Overview
        11.5.3 GlaxoSmithKline Attention Deficit Hyperactivity Disorder Introduction
        11.5.4 GlaxoSmithKline Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022)
        11.5.5 GlaxoSmithKline Recent Development
    11.6 Mallinckrodt
        11.6.1 Mallinckrodt Company Detail
        11.6.2 Mallinckrodt Business Overview
        11.6.3 Mallinckrodt Attention Deficit Hyperactivity Disorder Introduction
        11.6.4 Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022)
        11.6.5 Mallinckrodt Recent Development
    11.7 Hisamitsu
        11.7.1 Hisamitsu Company Detail
        11.7.2 Hisamitsu Business Overview
        11.7.3 Hisamitsu Attention Deficit Hyperactivity Disorder Introduction
        11.7.4 Hisamitsu Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022)
        11.7.5 Hisamitsu Recent Development
    11.8 Johnson & Johnson
        11.8.1 Johnson & Johnson Company Detail
        11.8.2 Johnson & Johnson Business Overview
        11.8.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder Introduction
        11.8.4 Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022)
        11.8.5 Johnson & Johnson Recent Development
    11.9 Purdue Parma
        11.9.1 Purdue Parma Company Detail
        11.9.2 Purdue Parma Business Overview
        11.9.3 Purdue Parma Attention Deficit Hyperactivity Disorder Introduction
        11.9.4 Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022)
        11.9.5 Purdue Parma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Attention Deficit Hyperactivity Disorder Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Stimulants Drugs
    Table 3. Key Players of Non-stimulants Drugs
    Table 4. Global Attention Deficit Hyperactivity Disorder Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Attention Deficit Hyperactivity Disorder Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Attention Deficit Hyperactivity Disorder Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Attention Deficit Hyperactivity Disorder Market Share by Region (2017-2022)
    Table 8. Global Attention Deficit Hyperactivity Disorder Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Attention Deficit Hyperactivity Disorder Market Share by Region (2023-2028)
    Table 10. Attention Deficit Hyperactivity Disorder Market Trends
    Table 11. Attention Deficit Hyperactivity Disorder Market Drivers
    Table 12. Attention Deficit Hyperactivity Disorder Market Challenges
    Table 13. Attention Deficit Hyperactivity Disorder Market Restraints
    Table 14. Global Attention Deficit Hyperactivity Disorder Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Attention Deficit Hyperactivity Disorder Market Share by Players (2017-2022)
    Table 16. Global Top Attention Deficit Hyperactivity Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit Hyperactivity Disorder as of 2021)
    Table 17. Ranking of Global Top Attention Deficit Hyperactivity Disorder Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Attention Deficit Hyperactivity Disorder Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Attention Deficit Hyperactivity Disorder Product Solution and Service
    Table 21. Date of Enter into Attention Deficit Hyperactivity Disorder Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Attention Deficit Hyperactivity Disorder Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Type (2017-2022)
    Table 25. Global Attention Deficit Hyperactivity Disorder Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Type (2023-2028)
    Table 27. Global Attention Deficit Hyperactivity Disorder Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Application (2017-2022)
    Table 29. Global Attention Deficit Hyperactivity Disorder Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Application (2023-2028)
    Table 31. North America Attention Deficit Hyperactivity Disorder Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Attention Deficit Hyperactivity Disorder Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Attention Deficit Hyperactivity Disorder Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Attention Deficit Hyperactivity Disorder Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Attention Deficit Hyperactivity Disorder Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Attention Deficit Hyperactivity Disorder Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Eli Lilly Company Detail
    Table 42. Eli Lilly Business Overview
    Table 43. Eli Lilly Attention Deficit Hyperactivity Disorder Product
    Table 44. Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022) & (US$ Million)
    Table 45. Eli Lilly Recent Development
    Table 46. Novartis Company Detail
    Table 47. Novartis Business Overview
    Table 48. Novartis Attention Deficit Hyperactivity Disorder Product
    Table 49. Novartis Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022) & (US$ Million)
    Table 50. Novartis Recent Development
    Table 51. Takeda Company Detail
    Table 52. Takeda Business Overview
    Table 53. Takeda Attention Deficit Hyperactivity Disorder Product
    Table 54. Takeda Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022) & (US$ Million)
    Table 55. Takeda Recent Development
    Table 56. Pfizer Company Detail
    Table 57. Pfizer Business Overview
    Table 58. Pfizer Attention Deficit Hyperactivity Disorder Product
    Table 59. Pfizer Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022) & (US$ Million)
    Table 60. Pfizer Recent Development
    Table 61. GlaxoSmithKline Company Detail
    Table 62. GlaxoSmithKline Business Overview
    Table 63. GlaxoSmithKline Attention Deficit Hyperactivity Disorder Product
    Table 64. GlaxoSmithKline Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022) & (US$ Million)
    Table 65. GlaxoSmithKline Recent Development
    Table 66. Mallinckrodt Company Detail
    Table 67. Mallinckrodt Business Overview
    Table 68. Mallinckrodt Attention Deficit Hyperactivity Disorder Product
    Table 69. Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022) & (US$ Million)
    Table 70. Mallinckrodt Recent Development
    Table 71. Hisamitsu Company Detail
    Table 72. Hisamitsu Business Overview
    Table 73. Hisamitsu Attention Deficit Hyperactivity Disorder Product
    Table 74. Hisamitsu Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022) & (US$ Million)
    Table 75. Hisamitsu Recent Development
    Table 76. Johnson & Johnson Company Detail
    Table 77. Johnson & Johnson Business Overview
    Table 78. Johnson & Johnson Attention Deficit Hyperactivity Disorder Product
    Table 79. Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022) & (US$ Million)
    Table 80. Johnson & Johnson Recent Development
    Table 81. Purdue Parma Company Detail
    Table 82. Purdue Parma Business Overview
    Table 83. Purdue Parma Attention Deficit Hyperactivity Disorder Product
    Table 84. Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder Business (2017-2022) & (US$ Million)
    Table 85. Purdue Parma Recent Development
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Attention Deficit Hyperactivity Disorder Market Share by Type: 2021 VS 2028
    Figure 2. Stimulants Drugs Features
    Figure 3. Non-stimulants Drugs Features
    Figure 4. Global Attention Deficit Hyperactivity Disorder Market Share by Application in 2021 & 2028
    Figure 5. Pediatric Case Studies
    Figure 6. Adolescent Case Studies
    Figure 7. Adults Case Studies
    Figure 8. Attention Deficit Hyperactivity Disorder Report Years Considered
    Figure 9. Global Attention Deficit Hyperactivity Disorder Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Attention Deficit Hyperactivity Disorder Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Attention Deficit Hyperactivity Disorder Market Share by Region: 2021 VS 2028
    Figure 12. Global Attention Deficit Hyperactivity Disorder Market Share by Players in 2021
    Figure 13. Global Top Attention Deficit Hyperactivity Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit Hyperactivity Disorder as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Attention Deficit Hyperactivity Disorder Revenue in 2021
    Figure 15. North America Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Attention Deficit Hyperactivity Disorder Market Share by Country (2017-2028)
    Figure 17. United States Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Attention Deficit Hyperactivity Disorder Market Share by Country (2017-2028)
    Figure 21. Germany Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Share by Region (2017-2028)
    Figure 29. China Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Attention Deficit Hyperactivity Disorder Market Share by Country (2017-2028)
    Figure 37. Mexico Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Share by Country (2017-2028)
    Figure 41. Turkey Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Eli Lilly Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2017-2022)
    Figure 44. Novartis Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2017-2022)
    Figure 45. Takeda Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2017-2022)
    Figure 46. Pfizer Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2017-2022)
    Figure 47. GlaxoSmithKline Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2017-2022)
    Figure 48. Mallinckrodt Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2017-2022)
    Figure 49. Hisamitsu Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2017-2022)
    Figure 50. Johnson & Johnson Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2017-2022)
    Figure 51. Purdue Parma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
Novartis
Takeda
Pfizer
GlaxoSmithKline
Mallinckrodt
Hisamitsu
Johnson & Johnson
Purdue Parma
Frequently Asked Questions
Attention Deficit Hyperactivity Disorder report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Attention Deficit Hyperactivity Disorder report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Attention Deficit Hyperactivity Disorder report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Biotextiles

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Bladder Cancer

Bladder Cancer market is segmented by players, region (country), by Type and by Application. Play ... Read More